The analyses of the obtained spectra were performed using our personal database [5 (link),6 (link)], the Bruker database updated with a laboratory collection of spectra from clinical isolates identified using molecular sequencing (primarily 16S rRNA sequencing) [6 (link)].
The criteria for identification were previously reported [5 (link)]. An isolate was considered correctly identified by MALDI-TOF MS if both spectra had a score ≥1.9 for species identification or ≥1.7 for genus identification [5 (link)].
Finally, positive controls are used in a routine manner for both MALDI-TOF MS systems. Besides, colonies are systematically tested in duplicate. The E. coli positive controls must be correctly identified and a same identification for the duplicate spots of each colony must be obtained using the score of each software package in order to conclude to the identification of microorganism.